Holding in Company

RNS Number : 1263V
Alliance Pharma PLC
03 July 2009
 



For immediate release

3 July 2009


ALLIANCE PHARMA PLC

 Notification of Major Interests in Shares




1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are

attached:
 

 

Alliance Pharma plc  

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights 


Other (please specify):

On market transfer between indirect and direct funds

 

YES

3. Full name of person(s) subject to the
notification obligation:
 

 

Aviva plc & its subsidiaries  

4. Full name of shareholder(s) 
 (if different from 3.):

Registered Holder:

 

BNP Paribas - London   

 

CUIM Nominee Limited     

 

Chase Nominees Limited  

*denotes direct interest

 



 

3,245,000


 

5,325,000*


 

10,355,755 


5. Date of the transaction and date on
which the threshold is crossed or

reached:

 

2 July 2009

6. Date on which issuer notified:

3 July 2009

 

7. Threshold(s) that is/are crossed or
reached:
 

<3% to 3% Change at Direct Interest Level

 


8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the 
triggering
transaction

Resulting situation after the triggering transaction

Number
of

Shares

Number
of

V
oting
Rights

Number
of shares

Number of voting
rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares
GB00
31030819

18,175,755

18,175,755

5,325,000

5,325,000

13,600,755

3.29%

8.39%




B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
 xiii

Exercise/ 
Conversion Period xiv

Number of voting
rights that may be

acquired if the

instrument is

exercised/ converted.

% of voting
rights








C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
 

Number of voting rights instrument refers to


% of voting rights 








Nominal

Delta



Total (A+B+C)

Number of voting rights

Percentage of voting rights

18,925,755

11.68%


9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
 xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-


Aviva Investors Global Services Limited:

Aviva plc (Parent Company)

Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)




  

Proxy Voting:

10. Name of the proxy holder:

See Section 4

11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:


Figures are based on a total number of voting rights of  162,061,774.

 

14. Contact name:

Neil Whittaker

 

15. Contact telephone number:

01603 684420

 




This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLZGGGNKFKGLZM
UK 100

Latest directors dealings